Pharmaceuticals and Drugs (FSS-61-IB)
Active Master GSA Schedule Awarded
- Federal agency
-
Veterans Integrated Service Network 12
- Awardees
- 732 across 1,077 IDV awards
- Task orders
- 15,032
- Obligated
- $2,271,599,788
Vehicle facts
- Opportunity
-
- M5Q50A03R2, 651B, M5Q50A03, 65IBDRUGSPHARMACEUTICALSHEMATOLOGYRELATEDPRODUCTFSSCONTRACTAWARD, M5Q50A03R6 and 5 more Solicitation numbers
- Agency
-
- Veterans Integrated Service Network 12 Veterans Health Administration, Department of Veterans Affairs
- Combined task order value
-
- $2,910,530,165 Current, with exercised options
- $3,107,546,829 Potential, with all options
- Last date to order
- No end date listed
- Also known as
-
- 65IB
IDV award and task order details come from SAM.gov/FPDS.
About this vehicle
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 established this Master GSA Schedule for pharmaceuticals and drugs on March 15, 1993, with ordering authority extending to September 29, 2103. The vehicle remains actively used, with 10,000 task orders awarded across six subcategories spanning single- and multiple-source drugs, IV delivery systems, nutritional supplements, non-prescription medicated products, generic pharmaceuticals, and antiseptic cleansing agents.
The combined potential value of all task orders is $3.09 billion, of which $2.21 billion (71%) has been obligated. Recent ordering momentum shows volatility: the vehicle averaged 528 orders annually over the past five years, with 2024 marking the peak at 671 orders and 2026 year-to-date at 342 orders. The most recent task order award occurred on September 30, 2026.
Scope spans specialty pharmaceuticals, biologics, diagnostic radiopharmaceuticals, and routine generic medications. Recent high-value orders include a $29.99 million amoxicillin trihydrate supply agreement, a $16.46 million lenalidomide ceiling (with $5.49 million obligated), a $4.56 million PSMA diagnostic order, and multiple $819,000 to $918,000 value orders for lenalidomide and similar specialty drugs. Most task orders range from $5,000 to $75,000, with firm-fixed-price structures and completion windows of 30 days to 12 months.
Competition is highly concentrated. CSL Behring L.L.C. holds 1,930 orders valued at $88 million combined potential. Actelion Pharmaceuticals US, Inc. (1,597 orders, $35.8 million) and Grifols Therapeutics LLC (838 orders, $25.6 million) rank second and third by order count. However, by potential value, Bayer Healthcare Pharmaceuticals Inc. ($54.9 million) and Emergent Devices, Inc. ($53.5 million) rank higher than Actelion. The top five primes account for 55% of task orders; the remaining 235 awardees fragment the long tail.
Customer concentration is extreme: the top five Veterans Integrated Service Networks (VISNs) place 59% of all orders, with VISN 12 placing 1,157 orders valued at $218.7 million combined potential. VISN 9 (1,416 orders, $58.3 million), VISN 5 (1,315 orders, $39.2 million), VISN 6 (995 orders, $51.2 million), and VISN 10 (970 orders, $70.7 million) complete the top tier. All orders are unrestricted, with no small-business set-asides in evidence across the portfolio.
Description
Non-prescription medicated cosmetics & surgical soaps
IDV awards
Show 40 more
Latest 50 of 1,077 listed here. See the rest on GovTribe.
Latest task orders
Show 15 more
Latest 25 of 15,032 listed here. See the rest on GovTribe.
Pools and SINs
| Pool or SIN | IDV awards |
|---|---|
| Single and multiple source drug | 916 |
| Generic and multiple source pharmaceuticals | 302 |
| Nutritional and Dietary Supplements | 52 |
| Antiseptic Liquid Skin Cleansing Detergents and Soaps and Topical Dressings | 40 |
| Non-prescription medicated products | 26 |
| IV delivery systems | 8 |
Top awardees by obligations
| Rank | Awardee | Obligated | Share |
|---|---|---|---|
| 1 | Chartwell RX LLC | $243,627,168 | 11% |
| 2 | Alvogen, Inc. | $227,679,088 | 10% |
| 3 | Partner Therapeutics, Inc. | $192,577,613 | 8% |
| 4 | Genentech Usa, Inc. | $164,618,897 | 7% |
| 5 | Exelan Pharmaceuticals Inc. | $157,753,891 | 7% |
| 6 | Progenics Pharmaceuticals Inc. | $126,074,340 | 6% |
| 7 | Kremers Urban Pharmaceuticals Inc. | $102,130,068 | 4% |
| 8 | CSL Behring L.L.C. | $67,776,532 | 3% |
| 9 | Sagent Pharmaceuticals, Inc. | $64,389,410 | 3% |
| 10 | Advanced Accelerator Applications USA Inc. | $61,894,056 | 3% |
Top funding agencies by obligations
| Rank | Funding agency | Obligated | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $1,182,145,848 | 52% |
| 2 | Department of Veterans Affairs | $1,019,139,328 | 45% |
| 3 | Department of Justice | $24,413,681 | 1% |
| 4 | Department of the Army | $12,542,785 | 1% |
| 5 | Department of State | $9,530,737 | <1% |
| 6 | Department of the Navy | $8,262,827 | <1% |
| 7 | Defense Health Agency | $8,058,137 | <1% |
| 8 | Department of Homeland Security | $2,752,542 | <1% |
| 9 | Air Force | $1,718,052 | <1% |
| 10 | Defense Logistics Agency | $622,489 | <1% |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | -$368,197 |
| FY2026 | $221,075,970 |
| FY2025 | $297,791,837 |
| FY2024 | $595,191,477 |
| FY2023 | $123,634,138 |
| FY2022 | $336,882,588 |
| FY2021 | $82,317,266 |
| FY2020 | $70,652,309 |
| FY2019 | $75,082,122 |
| FY2018 | $73,095,309 |
| FY2017 | $102,259,402 |
| FY2016 | $79,829,440 |
| FY2015 | $70,901,908 |
| FY2014 | $58,349,102 |
| FY2013 | $39,985,699 |
| FY2012 | $22,165,047 |
| FY2011 | $12,262,817 |
| FY2010 | $3,920,181 |
| FY2009 | $1,211,698 |
| FY2008 | $186,671 |
| FY2007 | $8,157 |
Show all 21
Quick answers
What is the FSS-61-IB contract vehicle?
Pharmaceuticals and Drugs (FSS-61-IB) is a GSA schedule run by Veterans Integrated Service Network 12 (Veterans Health Administration), awarded on March 15, 1993.
Which companies hold FSS-61-IB?
732 companies hold FSS-61-IB's 1,077 IDV awards. The latest went to Alembic Therapeutics LLC on November 1, 2026. The awardees whose task orders obligated the most are Chartwell RX LLC, Alvogen, Inc. and Partner Therapeutics, Inc.
How much has been spent through FSS-61-IB?
15,032 task orders have been placed under FSS-61-IB, obligating $2,271,599,788. Their combined current value, with exercised options, is $2,910,530,165.
Which agencies use FSS-61-IB the most?
The departments whose task orders under FSS-61-IB obligated the most are Department of Health and Human Services ($1,182,145,848), Department of Veterans Affairs ($1,019,139,328) and Department of Justice ($24,413,681).
How much was obligated through FSS-61-IB in fiscal year 2025?
Task orders under FSS-61-IB obligated $297,791,837 in fiscal year 2025.
What pools does FSS-61-IB have?
FSS-61-IB has 6 pools, lots and SINs, including Single and multiple source drug, Generic and multiple source pharmaceuticals, Nutritional and Dietary Supplements and Antiseptic Liquid Skin Cleansing Detergents and Soaps and Topical Dressings.
On GovTribe
See this vehicle's full record
- Every IDV award and task order
- Funding by agency, awardee, NAICS and set-aside
- Teaming partners on this vehicle
- Ask GovTribe AI about this vehicle